POA Pharma is now a Galen company

Galen, the privately owned global pharmaceutical sales and marketing company, is delighted to announce the acquisition and takeover of boutique healthcare company, POA Pharma.

New website coming soon


POA Pharma is a young, fast growing, profitable and unique international healthcare company with its base in Scandinavia.

Brief History

POA Pharma was on the market March 2011. POA Pharma has offices and marketing organisations in the four Nordic Countries. Central Marketing & Development: POA Pharma develop products for treatment of Inborn Error of Metabolism. The products is classified as “Food for Special Medical Purposes Tactical POA works within nine areas of competence. POA Pharma management has more than 150 years of collective experience in marketing diagnostics, nutrition, pharmaceuticals and OTC products.

A Boutique Company

POA Pharma is a market oriented Boutique Healthcare Company, working in close contact with healthcare organizations, professionals and pharmacies. Boutique is French for “shop”, via Latin from Greek apothēkē, “storehouse”. In contemporary business language boutique is a specialized firm with a unique concept.

“A Boutique is where you expect to be positively surprised when finding what the average shop cannot offer.“

A Flexible company

POA adapts to customer needs, and if necessary, extends its experience with associate members or specialists. This approach has implications for the way we view of our products. POA Pharma does not own the products we provide to the extent, that they must be sold at any price. We see them rather as tools to solve health care and patient problems. This approach allows us to be very flexible towards our customer.

We may not always have all the solutions to the customers’ problems but we do know where to find them.

A Research and product Developing company

Within the area of IEM we can see two trends today; More screenings in more countries resulting in more problems. Patients with PKU are getting older. Today the oldest treated PKU patient in Europe is around 45 – 50 years old. Treated patients today are not only kids and teenagers but middle aged adults and soon elderly people. The PKU society is also getting more and more differentiated and each group have their specific needs. This new situation calls for new ideas of dietary solutions and a greater variation. 2012 and 2013 POA introduced their owned PKU Concept, developed together with Scandinavian dieticians. No compromises in quality was the base for the development. In development and production terms, it means smaller quantities of more differentiated products – there is a need for “boutique thinking” a concept that differs from the classical thinking in long production series.

“POA Pharma’s areas of competence reflects our ambition to be responsive.”

Our mission, to offer unique medical products of therapeutic value, is appreciated by physicians, nurses, dietitians and other healthcare professionals, as well as by the patients and their families. Our product list is constantly being extended. Several products are in the registration process. Negotiations with international manufacturers are ongoing. POA Pharma contributes to better healthcare, better health and wellbeing and a higher quality of life.

At present – these are our areas of competence:

  • Abuse
  • Anesthesia
  • Cardiology
  • Female Care
  • Gastro
  • ENT
  • Metabolic diseases
  • Neurology
  • Urology

A Nordic Company

POA Pharma is a Pharmaceutical and Healthcare company with its base in Scandinavia. Scandinavia is our home market with offices and sales forces in Denmark, Finland, Norway and Sweden (Head office). We know and have long experiences with the Nordic healthcare markets and are familiar with the rules and regulations issued by the national and regional medical and pharmaceutical agencies.


There is a reason why we’re called POA Pharma Scandinavia. POA scan the four Nordic markets!